Back to results
US 12,590,077 B2Granted
Short-acting monoamine releasers
AssigneeSolvonics Therapeutics Ireland Holdings Limited
InventorsDavid Nutt, Alan Borthwick, Robin Tyacke
Life of this patent
Estimating the term…
Abstract
Disclosed herein are novel 1,3-benzodioxole esters and their homologues, having various advantages over current compounds used in certain methods of drug-assisted therapy, such as MDMA, together with pharmaceutical compositions containing such 1,3-benzodioxole esters, and methods of their use to treat CNS disorders, and in particular mental health disorders.
Claims20
A compound of Formula (A), or a pharmaceutically acceptable salt thereof:
- wherein:
- R1 is H, methyl, or ethyl;
- and
- R2 is —(CH2)n—CO2Y, where n is an integer between 0 and 4 inclusive, and Y is alkyl, cycloalkyl, aryl, or arylalkyl.
1 more element
Dependencies are inferred from the claim text.